The involvement of FGF/FGFRs in the pathology of many cancer types provides a strong rationale for development of effective agents for these targets and a large effort to develop FGFR inhibitors as anticancer treatments is underway (Brooks et al., 2012, Dieci et al., 2013).
If extreme poverty declines significantly over the next 20 years, as economic growth continues in the south, the rationale for development co-operation under a poverty eradication paradigm might diminish.
This paper reports on the rationale for development, design, and evaluation of a module of study for staff who care for children with complex needs and their families.
Hence inhibiting the eIF4F checkpoint suppresses tumor growth through multiple mechanisms and provides a rationale for development of broad-acting therapeutics.
These data indicate that Plasmodium SPP is a potential therapeutic target for malaria, and provide rationale for development of selective Plasmodium SPP inhibitors, perhaps based on the LY411,575 scaffold as novel treatments for malaria.
The rationale for development of the isotope-coded NEM approach was to allow future extension to measurement in parallel of both RSNO and SS protein modifications.
This provides the basis and rationale for development of knowledge-based learning outcomes for pharmacology that can inform pharmacology teaching across degree programs with minimum standards articulated for each degree program.
Thus there is a strong rationale for development of IGF-1R targeted therapies, and IGF-1R inhibition might be expected to enhance the effect of cytotoxic chemotherapies or other molecular targeted therapies.
It also provided a rationale for development of the Caspase-8 activity assay as a functional predictive biomarker that could allow better prediction of the response to IAPi+TRA-based therapies than the analysis of expression levels of protein biomarkers.
Moreover, obstacles to widespread use of non-pharmacological therapy rather than analgesic drugs need to be explored because the rationale for development of non-pharmacological therapy in critical care is strong.
